Literature DB >> 24468422

Enhancing expression of the classical swine fever virus glycoprotein E2 in yeast and its application to a blocking ELISA.

Chih-Yuan Cheng1, Ching-Wei Wu1, Guang-Jan Lin1, Wei-Cheng Lee2, Maw-Sheng Chien3, Chienjin Huang4.   

Abstract

Classical swine fever virus (CSFV) infection is a severe swine disease, often causing large economic losses. A Pichia pastoris yeast-expressed CSFV glycoprotein E2 (yE2) has been shown to induce a protective immune response against the virus. To improve the expression level of yE2, the first codon of E2 gene, Arg (CGG), which is the least used in P. pastoris, was optimized to the most favorite codon AGA. The yield of E2 protein was remarkably increased in the codon optimized strain (N342). Three truncated E2 subunits encoding the N-terminal 330 (N330), 301 (N301), and 190 (N190) residues, respectively, were also constructed. The immunogenicity of each recombinant E2 subunits was confirmed by immunization of pigs, and all immunized groups demonstrated high neutralizing antibody titers after boost immunization, which lasted for a long period of time. In addition, a monoclonal antibody (MAb), 1B6, specific to yE2, was generated and shown to recognize CSFV-infected cells. A panel of swine sera were tested by peroxidase-conjugated MAb 1B6-based blocking enzyme-linked immunosorbent assay (ELISA) using N330 as coated antigen, and the assay demonstrated high sensitivity and specificity. The recombinant yE2 subunits may provide potential subunit vaccine candidates and useful diagnostic reagents for CSFV with easy manipulation and low cost.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blocking ELISA; Classical swine fever virus; Codon optimization; Monoclonal antibody; Subunit marker vaccine

Mesh:

Substances:

Year:  2014        PMID: 24468422     DOI: 10.1016/j.jbiotec.2014.01.007

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  5 in total

1.  Effectiveness of the E2-classical swine fever virus recombinant vaccine produced and formulated within whey from genetically transformed goats.

Authors:  O Sánchez; M Barrera; O Farnós; N C Parra; E R Salgado; P A Saavedra; C D Meza; C I Rivas; M Cortez-San Martín; J R Toledo
Journal:  Clin Vaccine Immunol       Date:  2014-10-01

2.  Designing a novel E2-IFN-γ fusion protein against CSFV by immunoinformatics and structural vaccinology approaches.

Authors:  Yanmin Zhang; Weijian Zhang; Jun Cheng; Xuping Liu; Shiwei Miao; Wen-Song Tan; Liang Zhao
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-07       Impact factor: 4.813

Review 3.  Contribution of yeast models to virus research.

Authors:  R Sahaya Glingston; Jyoti Yadav; Jitika Rajpoot; Neha Joshi; Shirisha Nagotu
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-04       Impact factor: 4.813

Review 4.  Structures and Functions of Pestivirus Glycoproteins: Not Simply Surface Matters.

Authors:  Fun-In Wang; Ming-Chung Deng; Yu-Liang Huang; Chia-Yi Chang
Journal:  Viruses       Date:  2015-06-29       Impact factor: 5.048

5.  Identification of E2 with improved secretion and immunogenicity against CSFV in piglets.

Authors:  Huiling Xu; Yanli Wang; Guangwei Han; Weihuan Fang; Fang He
Journal:  BMC Microbiol       Date:  2020-02-04       Impact factor: 3.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.